4-((2,2-dimethyl-1-oxopropyl)amino)butanoic acid,
N-trimethylacetyl GABA,
N-trimethylacetyl-4-aminobutyric acid,
pivagabin,
pivagabine,
Tonerg,
4-Pivalamidobutanoic acid,
Pivagabine,
69542-93-4,
4-[(2,2-dimethylpropanoyl)amino]butanoic acid,
UNII-C53SV0WO4V,
Pivagabine [INN],
C53SV0WO4V,
4-(2,2-dimethylpropanoylamino)butanoic acid,
Pivagabine (INN),
4-(2,2-DIMETHYLPROPIONYLAMINO)BUTYRIC ACID,
NCGC00160457-01,
4-(2,2-dimethylpropanamido)butanoic acid,
4-[(2,2-dimethylpropionyl)amino]butyric acid,
DSSTox_CID_26162,
DSSTox_RID_81393,
DSSTox_GSID_46162,
Tonerg,
CAS-69542-93-4,
4-((2,2-Dimethylpropionyl)amino)butyric acid,
SR-01000945179,
CXB-722,
EINECS 274-038-3,
N-Trimethylacetyl-4-aminobutyric acid,
4-Pivalamidobutyric acid,
AC1L2ANP,
AC1Q1LQR,
4-Pivalamido-butyric acid,
AC1Q5P7B,
SCHEMBL96152,
Butyric acid, 4-pivalamido-,
N-Pivaloyl-4-aminobutyric acid,
CHEMBL1870796,
DTXSID3046162,
NIOSH/ET6170000,
CTK7F3860,
CHEBI:134834,
ACT10073,
ZINC1545856,
Tox21_111827,
ANW-46453,
MFCD00868454,
AKOS000127419,
Tox21_111827_1,
DB12951,
MCULE-4742309462,
NE35870,
NCGC00160457-02,
AJ-26876,
DA-18317,
LS-48165,
AB0007261,
ST2405938,
TC-135198,
4- (2,2-Dimethylpropionylamino)butyric acid,
ET61700000,
FT-0744708,
W7931,
4-(2,2-Dimethyl-propionylamino)-butyric acid,
EN300-27463,
D07342,
J-514186,
SR-01000945179-1,
SR-01000945179-2,
Z85888809,
Butanoic acid, 4-((2,2-dimethyl-1-oxopropyl)amino)-,
pivagabin,
4-[ amino]butyricacid,
4-Pivalamidobutanoicacid,
D06XKB,
D0R8PE,
C9H17NO3,
CXB722,
C9-H17-N-O3,
CID68888,
AR-1K8222,
62803-78-5,